US › Healthcare

Rxsight Inc (RXST)

US · Healthcare · Medical Devices

$6.25-0.64%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$30.9M
Revenue YoY
-18.5%
Net profit
$-15.9M
Profit YoY
-93.9%
EPS
$-0.19
EPS estimate
$-0.15
Net margin
-51.4%

EPS came in at -0.19 against a street estimate of -0.15 — a miss of 26.7%.

Key statistics

Market cap
$248.8M
Forward P/E
116.3
P/B
0.93
Book value
$6.46
EPS (TTM)
$-1.13
52-week high
$13.22
52-week low
$4.48
50-day MA
$5.31
200-day MA
$7.84
Beta
1.15

Analyst view

Analysts rate Rxsight Inc a buy (6 buy, 3 hold, 2 sell out of 11) with an average price target of $8.06.

Shareholding

Insiders
6.45%
Institutions
92.90%

Largest institutional holders

FundStake
BlackRock Inc7.70%
Millennium Management LLC4.97%
Artisan Partners Limited Partnership4.97%
Nomura Holdings Inc4.83%
No Street GP LP4.83%
D. E. Shaw & Co LP4.73%
Vanguard Capital Management, LLC4.09%
Two Sigma Investments LLC3.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Rxsight Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.